Literature DB >> 23904924

Dyskeratosis congenita- management and review of complications: a case report.

Shivam Sinha1, Vikas Trivedi, Arvind Krishna, Nidhi Rao.   

Abstract

Among the inherited bone marrow failure disorders, dyskeratosis congenita is an X-linked inherited disorder arising as a consequence of short telomere and mutations in telomere biology. Production of the altered protein dyskerin, leads to vulnerable skin, nails, and teeth which lead to higher permeability for noxious agents which can induce carcinogenesis accounting for the classical triad of skin pigmentation, nail dystrophy and oral leukoplakia. This condition is fatal and patients succumb to aplastic anemia, malignancy or immunocompromised state. We present a young male with the classic clinical triad and avascular necrosis of both femoral heads, with no evidence of hematologic anomaly or any malignancy. He was managed for osteonecrosis with uncemented total hip arthroplasty for the symptomatic left hip. Our case represents a benign form of such a fatal and rare condition, which if detected and managed early can result in improved quality of life for the patient suffering from this disorder. This patient is under our meticulous follow-up for the last 2 years in order to determine any late development of complications before being labelled as a variant of this syndrome.

Entities:  

Keywords:  Dyskeratosis congenita; Dyskerin; Inherited bone marrow failure syndrome; Leukoplakia; Osteonecrosis

Year:  2013        PMID: 23904924      PMCID: PMC3725241          DOI: 10.5001/omj.2013.78

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  15 in total

1.  Cole-Engman syndrome associated with leukoplakia of the tongue: a case report.

Authors:  A Tanaka; S Kumagai; K Nakagawa; E Yamamoto
Journal:  J Oral Maxillofac Surg       Date:  1999-09       Impact factor: 1.895

2.  Oral-dental findings in dyskeratosis congenita.

Authors:  E Yavuzyilmaz; N Yamalik; S Yetgin; O Kansu
Journal:  J Oral Pathol Med       Date:  1992-07       Impact factor: 4.253

Review 3.  Dyskeratosis congenita: a disorder of defective telomere maintenance?

Authors:  Amanda J Walne; Anna Marrone; Inderjeet Dokal
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

4.  Keratinization and its disorders.

Authors:  Shibani Shetty
Journal:  Oman Med J       Date:  2012-09

5.  Bilateral coats retinopathy associated with aplastic anaemia and mild dyskeratotic signs.

Authors:  P Kajtár; K Méhes
Journal:  Am J Med Genet       Date:  1994-02-15

6.  Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome?

Authors:  T Revesz; S Fletcher; L I al-Gazali; P DeBuse
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

7.  Dyskeratosis congenita: two examples of this multisystem disorder.

Authors:  R Womer; J E Clark; P Wood; H Sabio; T E Kelly
Journal:  Pediatrics       Date:  1983-04       Impact factor: 7.124

Review 8.  Dyskeratosis congenita: report of a case and review of the literature.

Authors:  G R Ogden; E Connor; D M Chisholm
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1988-05

Review 9.  Dyskeratosis congenita and telomerase.

Authors:  Monica Bessler; David B Wilson; Philip J Mason
Journal:  Curr Opin Pediatr       Date:  2004-02       Impact factor: 2.856

10.  Thrombocytopenia: first symptom in a patient with dyskeratosis congenita.

Authors:  K De Boeck; H Degreef; R Verwilghen; L Corbeel; M Casteels-Van Daele
Journal:  Pediatrics       Date:  1981-06       Impact factor: 7.124

View more
  3 in total

1.  Kindler syndrome: a close mimic of dyskeratosis congenita and the need to distinguish the two clinical entities.

Authors:  Shailendra Kapoor
Journal:  Oman Med J       Date:  2014-03

Review 2.  Genodermatoses.

Authors:  N Aravindha Babu; E Rajesh; Jayasri Krupaa; G Gnananandar
Journal:  J Pharm Bioallied Sci       Date:  2015-04

Review 3.  The diagnosis and treatment of dyskeratosis congenita: a review.

Authors:  M Soledad Fernández García; Julie Teruya-Feldstein
Journal:  J Blood Med       Date:  2014-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.